Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer
Clinical trial NCT03430700 · COMPLETED
Trial details
- NCT number
- NCT03430700
- Sponsor
- University College, London
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2025-12-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.